{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:43:13Z","timestamp":1780098193412,"version":"3.54.0"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Breast cancer is the most common cancer in women. The neutrophil\/lymphocyte ratio (NLR) is an emerging biomarker from peripheral blood that has been associated with breast cancer prognosis in some studies; however, some studies fail to demonstrate an association. We stratified breast cancer patients into invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) cohorts to evaluate if any meaningful association could be found in either cohort between NLR and mortality. Additionally, no prior studies have examined the relationship between NLR and background parenchymal enhancement (BPE) on breast MRI, an imaging feature linked to increased breast cancer risk and a potential imaging prognostic biomarker, so we examined the relationship between BPE and NLR in the two cohorts. Methods: This retrospective study included 794 breast cancer patients who had either IDC or ILC. Radiologists\u2019 MRI reports and their BI-RADS categorization of BPE (1 = minimal, 2 = mild, 3 = moderate, 4 = marked) were extracted and recorded. The NLR was calculated from blood counts obtained prior to treatment. Tumor characteristics were also recorded. Results: For patients with ILC, NLR was found to be associated with mortality. Additionally, patients with ILC and a high BPE had a significantly higher mean NLR compared to all other groups, including low BPE groups and all IDC groups. Conclusions: There is potential value in using NLR, a readily available blood biomarker, in models predicting prognosis in ILC patients.<\/jats:p>","DOI":"10.3390\/diagnostics16030449","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:12:46Z","timestamp":1770041566000},"page":"449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Neutrophil\/Lymphocyte Ratio as a Potential Biomarker Stratified by Breast Cancer Histologic Subtype"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7862-7005","authenticated-orcid":false,"given":"Emily","family":"Hunt","sequence":"first","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Bains","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Darby","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2231-0172","authenticated-orcid":false,"given":"Roham","family":"Hadidchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-2827","authenticated-orcid":false,"given":"Tim Q.","family":"Duong","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takouhie","family":"Maldjian","sequence":"additional","affiliation":[{"name":"Department of Radiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Alves, L.N.R., Meira, D.D., Merigueti, L.P., Casotti, M.C., Ventorim, D.D.P., Almeida, J.F.F., de Sousa, V.P., Sant\u2019ana, M.C., da Cruz, R.G.C., and Louro, L.S. (2023). Biomarkers in Breast Cancer: An Old Story with a New End. Genes, 14.","DOI":"10.3390\/genes14071364"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101719","DOI":"10.1016\/j.xcrm.2024.101719","article-title":"Radiomics in breast cancer: Current advances and future directions","volume":"5","author":"Qi","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_3","unstructured":"The American Cancer Society Medical and Editorial Content Team (2025, May 05). Key Statistics for Breast Cancer. Available online: https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/about\/how-common-is-breast-cancer.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3747\/co.25.3888","article-title":"Neutrophil-lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer","volume":"25","author":"Chae","year":"2018","journal-title":"Curr. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13058-023-01761-x","article-title":"Prognostic value of baseline neutrophil\/lymphocyte ratio in HER2-positive metastatic breast cancer: Exploratory analysis of data from the CLEOPATRA trial","volume":"26","author":"Ding","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"znae132","DOI":"10.1093\/bjs\/znae132","article-title":"Predictive value of pretreatment circulating inflammatory response markers in the neoadjuvant treatment of breast cancer: Meta-analysis","volume":"111","author":"Dowling","year":"2024","journal-title":"Br. J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ebaid, N.F., Abdelkawy, K.S., Said, A.S.A., Al-Ahmad, M.M., Shehata, M.A., Salem, H.F., and Hussein, R.R.S. (2025). Is the Neutrophil-to-Lymphocyte Ratio a Predictive Factor of Pathological Complete Response in Egyptian Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?. Medicina, 61.","DOI":"10.3390\/medicina61020327"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Faur, I.F., Dobrescu, A., Clim, I.A., Pasca, P., Burta, C., Tarta, C., Brebu, D., Neamtu, A.-A., Braicu, V., and Duta, C. (2025). Prognostic Significance of Peripheral Blood Parameters as Predictor of Neoadjuvant Chemotherapy Response in Breast Cancer. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062541"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Jia, W., Wu, J., Jia, H., Yang, Y., Zhang, X., Chen, K., and Su, F. (2015). The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143061"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Son, N.H., Lee, J.S., Mun, J.E., Kim, J.Y., Park, H.S., Park, S., Kim, S.I., and Park, B.W. (2021). Time-Sequencing of the Neutrophil-to-Lymphocyte Ratio to Predict Prognosis of Triple-Negative Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13143472"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kim, J.Y., Jung, E.J., Kim, J.M., Lee, H.S., Kwag, S.J., Park, J.H., Park, T., Jeong, S.H., Jeong, C.Y., and Ju, Y.T. (2020). Dynamic changes of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predicts breast cancer prognosis. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07700-9"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1038\/s41598-024-63318-y","article-title":"Predictive efficacy of the preoperative neutrophil-lymphocyte ratio in lymph node metastasis of cN0 hormone receptor-positive breast cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.1016\/j.clbc.2025.05.010","article-title":"Prognostic Value of Immune-Inflammation Indexes for Breast Cancer Patients Undergoing Endocrine Therapy: A Systematic Review and Meta-analysis","volume":"25","author":"Yang","year":"2025","journal-title":"Clin. Breast Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e047957","DOI":"10.1136\/bmjopen-2020-047957","article-title":"Role of neutrophil-to-lymphocyte ratio as a prognostic biomarker in patients with breast cancer receiving neoadjuvant chemotherapy: A meta-analysis","volume":"11","author":"Zhou","year":"2021","journal-title":"BMJ Open"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Rimando, J., Campbell, J., Kim, J.H., Tang, S.-C., and Kim, S. (2016). The Pretreatment Neutrophil\/Lymphocyte Ratio Is Associated with All-Cause Mortality in Black and White Patients with Non-metastatic Breast Cancer. Front. Oncol., 6.","DOI":"10.3389\/fonc.2016.00081"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10549-024-07286-x","article-title":"Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: Lack of prognostic utility and biological correlates across tumor subtypes","volume":"205","author":"Ramos","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10549-013-2493-2","article-title":"Invasive ductal carcinoma with lobular features: A comparison study to invasive ductal and invasive lobular carcinomas of the breast","volume":"138","author":"Arps","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1148\/radiol.2019182441","article-title":"The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis","volume":"292","author":"Thompson","year":"2019","journal-title":"Radiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13058-020-01375-7","article-title":"Association of breast cancer with MRI background parenchymal enhancement: The IMAGINE case-control study","volume":"22","author":"Watt","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104487","DOI":"10.1016\/j.ebiom.2023.104487","article-title":"Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: Comparison with influenza","volume":"90","author":"Lu","year":"2023","journal-title":"EBioMedicine"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Peng, T., Duong, K.S., Lu, J.Y., Chacko, K.R., Henry, S., Hou, W., Fiori, K.P., Wang, S.H., and Duong, T.Q. (2024). Incidence, characteristics, and risk factors of new liver disorders 3.5 years post COVID-19 pandemic in the Montefiore Health System in Bronx. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0303151"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e241919","DOI":"10.1148\/radiol.241919","article-title":"Impact of Background Parenchymal Enhancement on Diagnostic Performance of Breast MRI: A Systematic Review and Meta-Analysis","volume":"315","author":"Bechyna","year":"2025","journal-title":"Radiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1038\/s41598-018-25357-0","article-title":"Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism","volume":"8","author":"Du","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e230269","DOI":"10.1148\/radiol.230269","article-title":"Assessment of Background Parenchymal Enhancement at Dynamic Contrast-enhanced MRI in Predicting Breast Cancer Recurrence Risk","volume":"310","author":"Arefan","year":"2024","journal-title":"Radiology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmri.26762","article-title":"Background parenchymal enhancement on breast MRI: A comprehensive review","volume":"51","author":"Liao","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"19185","DOI":"10.1038\/s41598-019-55820-5","article-title":"Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer","volume":"9","author":"Moliere","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2214\/AJR.20.23804","article-title":"Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk","volume":"217","author":"Niell","year":"2021","journal-title":"Am. J. Roentgenol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.7314\/APJCP.2014.15.23.10363","article-title":"Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer","volume":"15","author":"Ozyalvacli","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.21037\/atm-22-5612","article-title":"The prognostic value of neutrophil-to-lymphocyte ratio in de novo stage IV breast cancer: A retrospective cohort study","volume":"11","author":"Shao","year":"2023","journal-title":"Ann. Transl. Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/3\/449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:30:17Z","timestamp":1770042617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/3\/449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["diagnostics16030449"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16030449","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}